Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo.
Lena AllweissKatja GierschAndrea PirosuTassilo VolzRobert C MuenchRudolf K BeranStephan UrbanHassan JavanbakhtSimon P FletcherMarc LütgehetmannMaura DandriPublished in: Gut (2021)
These results reveal that therapeutics abrogating all HBV transcripts including HBx promote epigenetic suppression of the HBV minichromosome, whereas strategies protecting the human hepatocytes from reinfection are needed to maintain cccDNA silencing.